References
- Kanz, L., Brugger, W. and Mertelsmann, R. (1994). The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation. Semin. Oncol., 21, Suppl. 16, 10–18.
- American Society of Clinical Oncology recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines (1994). J. Clin. Oncol., 12, 2471–2508.
- Quesenberry, P. J. (1993). Growth factor frenzy. Exp. Hematol., 21, 835–836.
- Vose, J. M. and Armitage, J. O. (1995). Clinical applications of hematopoietic growth factors. J. Clin. Oncol., 13, 1023–1035.
- Goodnough, L. T. and Anderson, K. C. (1995). Recombinant growth factors. Transfus Sci., 16, 45–62.
- Yalçin, S., Güler, N., Kansu, E., Ertenli, I., Güllü, I., Barişta, I. et al. (1996). Granulocyte-colony stimulating factor (G-CSF) administration for chemotherapy-induced neutropenia. Hematology, 1, 155–161.
- Smith, T. J. (1996). Economic analysis of the clinical uses of the colony-stimulating factors. Curr. Opin. Hematol., 3, 175–179.
- Souêtre, E., Qing, W. and Pénelaud, P. F. (1996). Economic analysis of the use of recombinant human granulocyte colony stimulating factor in autologous bone marrow transplantation. Eur. J. Cancer, 32A, 1162–1165.
- Boogaerts, M. A. and Demuynck, H. M. (1996). Consensus on the clinical use of myeloid growth factors. Curr. Opin. Hematol., 3, 241–246.
- Gulati, S. C. and Bitran, J. D. (1995). Cost-effectiveness analysis: sleeping with an enemy or a friend? J. Clin. Oncol., 13, 2151–2154.
- Szilvassy, S. J. and Hoffman, R. (1996). Hematopoietic growth factors do not accelerate neutrophil recovery after transplantation of optimally mobilized peripheral blood stem cells. Biol. Blood Marrow Transplant, 2, 2.
- Klumpp, T. R., Goldberg, S. L., Magdalinski, A. J. and Mangan, K. F. (1996). Effect of hematopoietic growth factors on the rate of neutrophil recovery following peripheral blood stem cell transplantation. Biol. Blood Marrow Transplant, 2, 1.